TC BioPharm (Holdings) plc Accounts Payable

The latest accounts payable for TCBP is $940K as of June 2024. That compares with $950K in the prior-year period — down 1.2% year over year. Investors often review this figure alongside TC BioPharm (Holdings) plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, TCBP's accounts payable moved from $950K to $940K — a 1.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TC BioPharm (Holdings) plc's operating scale or balance-sheet position.

A accounts payable figure of $940K for TCBP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TCBP's accounts payable ($940K), review year-over-year change from $950K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.